The only directory that connects you with VC firms investing in biotechnology and device companies. Perfect for anyone looking for financing: Seed, Series A-B, Series C-D, Mezzanine, Bridge, and Buyout.

In the current economic environment, biotech and device companies are now feverishly trying to "extend the runway" before running out of money. In the midst of the financial turmoil surrounding the industry, it is becoming increasingly difficult to find new sources of funding.

This unique directory, researched and written by BioAbility and published by BioWorld Today, couldn't come at a better time. It will help you locate investors that are still investing in the biotech and device industry. With this directory, you will be able to:

• Pinpoint firms that are investing in companies similar to yours!
• Find out if the VC has a specific scientific/technological interest!
• Learn the preferred stages of investment for each VC (Seed, Bridge, Series A-B, etc.)!
• Plan site visits using the regional index included in the directory!

BioAbility and BioWorld's Biotechnology and Medical Device VC Directory 2009 provides you access to each VC's portfolio, along with a comprehensive list of relevant subsidiary sites. You get a listing of the partners' names, locations, site phone numbers and many e-mail addresses. Coverage includes VCs located in the U.S., Canada, Europe, Israel, and Asia Pacific.

• 952 VC firms are profiled at 1,595 locations.
• 757 in the U.S, 67 in Canada, 460 in Europe, 278 in Asia Pacific and 33 in Israel.
• 2,884 individuals are included (e-mails are listed for many).

Groups needing this report:

• Biotech and device companies in need of funding.
• Venture capital firms looking for co-investors.
• Local governments and support groups looking to facilitate funding programs.
• Attorneys seeking to retain new clients.

How To Order:

Order BioAbility and BioWorld's Biotechnology and Medical Device VC Directory 2009 risk-free for 30 days for only $599 (plus $17.95 s&h) by choosing an option below. Or call us at 1-800-688-2421 or 1-404-262-5476 and mention priority code S09402-EM7017.